Bioequivalence of marketed transdermal delivery systems for tulobuterol

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 8, 2007, Pages 1576-1579

  Tojo, Kakuji ^a   Hikima, Tomohiro ^a  

^a KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Bioequivalence; Penetration; Release; Transdermal delivery; Tulobuterol

Indexed keywords

TULOBUTEROL;

ANIMAL TISSUE; ARTICLE; BIOEQUIVALENCE; COMPARATIVE STUDY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG MARKETING; DRUG PENETRATION; IN VITRO STUDY; MOUSE; NONHUMAN; PERFORMANCE; PERMEABILITY BARRIER; SIMULATION; SKIN; SKIN PENETRATION; SKIN PERMEABILITY; STRATUM CORNEUM; THICKNESS; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-AGONISTS; ANIMALS; CHEMISTRY, PHYSICAL; DIFFUSION CHAMBERS, CULTURE; DRUG DELIVERY SYSTEMS; MICE; MICE, INBRED HRS; SKIN ABSORPTION; TERBUTALINE; THERAPEUTIC EQUIVALENCY;

EID: 34548014104     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1576     Document Type: Article

References (7)

1. Tojo K., Keshary P. R., Chien Y. W., Chem. Eng. J., 32, B57-B64 (1986).
2. Tojo K., "Mathematical Models of Transdermal and Topical Drug Delivery," 2nd ed., Biocom Systems, Fukuoka, 2005.
3. Tojo K., Chiang C. C., Chien Y. W., J. Pharm. Sci., 76, 123-126 (1987).
4. Agacche P., Humbert P., "Measuring the Skin," Springer, New York, 2004.
5. Martin A., "Physical Pharmacy," 4th ed., Chap. 19, Lea & Febiger, PA, 1993.
6. Takahashi M., Ikezawa Z., "Dry skin in atopic dermatitis and patients on hemodialysis, dry skin and moisturizers: Chemistry and Function." CRC Press, Boca Raton, FL, 2000.
7. Bronaugh R. L., Maibach H. I., "Percutaneous Absorption, Drugs-Cosmetics-Mechanisms-Methodology," Marcel Dekker, New York, 1999, p. 128.